The invention refers to the use of an engineered 'Clustered Regularly Interspersed Short Palindromic Repeat (CRISPR)-CRISPR associated (Cas)’ (CRISPR-Cas) technology targeting a sequence mutated at one or more loci in the genome of a given eukaryotic cell
The compounds of the present invention are pyrazole[4,3-b]pyridin-6-carboxamide derivatives characterised by direct antibacterial activity against several Gram-positive bacteria
The present invention represents an in vitro implementable method and related kit for assessing the response to immune tolerance restoration therapy by evaluating the expression of specific microRNAs (miRNAs) as biomarkers of residual beta-cell function
the present invention consists of an electromechanical stimulation system, and related wearable device, generating and transmitting mechanical vibrations to the bone processes near a user's ear.
The invention concers compounds that act directly on the extracellular virus.
The invention consists of alternative compounds to nitisinone, for the treatment of both AKU and HT1.
The present invention provides an in vitro and ex vivo method using novel diagnostic probes with a specific spectrum detected by infrared (IR) spectroscopy.
The present invention serves the development of new therapeutic strategies and new non-opioid drugs for the treatment of pain
The invention relates to an hydro-alcoholic solution extract of selected grape pomace, a cosmetic formulation comprising such hydro-alcoholic solution extract, the method for incorporating the hydro-alcoholic solution extract into a cosmetic formulation and the final use of the as-obtained cosmetic [...]
the purpose of this invention is to provide a biological housing system capable of undergoing highly controlled ultrasonic stimulations, capable of guaranteeing, at the same time, practicality and simplicity of use, low cost and complete sterility of the biological samples [...]
